SynthesisBMC gastroenterology2024

Risk of Clostridioides difficile infection in inflammatory bowel disease patients undergoing vedolizumab treatment: a systematic review and meta-analysis.

Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.